Understand the source comparison
Biological Function: Signalling vs Catalysis
The peptides vs proteins difference determines biological role. Peptides primarily serve as signalling molecules, hormones, and receptor ligands. They bind targets and trigger downstream effects without catalysing chemical reactions themselves. Proteins functi
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The peptides vs proteins difference determines biological role. Peptides primarily serve as signalling molecules, hormones, and receptor ligands. They bind targets and trigger downstream effects without catalysing chemical reactions themselves. Proteins function as enzymes (catalysing reactions by stabilising transition states), structural scaffolds (collagen, keratin), transport carriers (haemoglobin, albumin), and immune effectors (antibodies). The functional gap traces directly to structural capacity: enzymatic catalysis requires a precisely shaped active site that positions substrate molecules and stabilises high-energy intermediates. Peptides lack the folding complexity to create these microenvironments.
- Growth hormone secretagogues like MK 677 (a peptide mimetic) and Hexarelin bind ghrelin receptors in the pituitary and hypothalamus, triggering growth hormone release through G-protein-coupled receptor activation. They don't synthesise growth hormone. That requires the ribosomal machinery and chaperone proteins inside somatotroph cells. The peptides vs proteins difference here is signal versus synthesis: peptides carry the message; proteins execute the biochemical work.
- Enzymatic proteins lower activation energy barriers by factors of 10^6 to 10^17. Reaction rates that would take millennia without catalysis occur in milliseconds. This catalytic power depends on active-site geometry: carbonic anhydrase (259 amino acids) positions a zinc ion, three histidine residues, and a precisely oriented water molecule to catalyse CO2 hydration at near-diffusion-limited rates (10^6 reactions per second). No peptide achieves this because active-site construction requires distant residues (positions 50, 100, and 200 in the sequence, for instance) to converge spatially. Only possible through stable tertiary folding. Our team has observed this in client research: studies attempting to engineer catalytic peptides invariably hit the folding barrier at around 40–45 amino acids, where structural instability prevents reproducible active-site formation.